Position in LH
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,261,400
+$2,858 QoQ
Shares Held
4,505
-4.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#421
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026HARTFORD INVESTMENT MANAGEMENT CO holds $30,356,534 across 11 Diagnostics & Research names. LH ranks #9 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
20,546 | $10,300,942 | |
| 2 | DHR |
Danaher Corp /De/
|
34,835 | $6,635,370 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
4,345 | $2,287,381 | |
| 4 | A |
Agilent Technologies, Inc.
|
15,600 | $2,072,148 | |
| 5 | WAT |
Waters Corp /De/
|
5,406 | $2,027,466 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
9,192 | $1,776,078 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
1,116 | $1,425,701 | |
| 8 | DGX |
Quest Diagnostics Inc
|
6,092 | $1,291,199 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,261,400 | 4,505 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,258,542 | 4,717 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,197,701 | 4,774 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,395,111 | 4,860 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,317,800 | 5,020 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $1,185,810 | 5,095 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,180,539 | 5,148 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $1,172,823 | 5,248 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,094,680 | 5,379 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||